title: Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety.
abstract: BACKGROUND
  Melasma is a relatively common, acquired symmetric hypermelanosis characterized by irregular light to gray-brown macules involving sun-exposed areas. Kojic acid, with its depigmenting potential due to tyrosinase inhibition and suppression of melanogenesis, has become a vital component of the dermatologists' armamentarium against melasma.
  
  
  OBJECTIVE
  To study and compare the efficacy of kojic acid 1% alone, vis-a-vis its separate combinations with 2% hydroquinone or 0.1% betamethasone valerate and a combination of all these three agents with respect to the duration of symptoms and level of pigmentation in the therapy of melasma.
  
  
  METHODS
  Eighty patients from a single tertiary care center objectively assessed by calculating the melasma area severity index (MASI) and randomized (simple randomization) into four parallel groups (A, B, C, and D) of 20 each were prescribed once daily local application at night, (participants blinded regarding the difference in identity of interventions), as follows: Group A - kojic acid 1% cream. Group B - kojic acid 1% and hydroquinone 2% cream. Group C - kojic acid 1% and betamethasone valerate 0.1% cream. Group D - kojic acid 1%, hydroquinone 2%, and betamethasone valerate 0.1% cream. Strict photoprotection and use of a SPF 15 sunscreen was advised during the day. Patients were evaluated every 2 weeks and a fall in MASI score was calculated at the end of the study period of 12 weeks by the same investigator.
  
  
  RESULTS
  The response was compared according to percentage decrease in MASI score. Efficacy was evaluated among the groups at the end of 3 months using bivariate analysis and calculated by using the paired 't' test. The clinical efficacy of group B was the highest followed closely by group D and group A, that of group C being the lowest.
  
  
  CONCLUSIONS
  Kojic acid in synergy with hydroquinone is a superior depigmenting agent as compared with other combinations.
authors.affiliation: Department of Dermatology, Padmashree Dr. D.Y. Patil Medical College and Hospital (Dr. D. Y Patil Vidyapeeth) Pimpri, Pune, India.
authors.forename: Kirti S
authors.initials: KS
authors.lastname: Deo
authors.forename: Kedar N
authors.initials: KN
authors.lastname: Dash
authors.forename: Yugal K
authors.initials: YK
authors.lastname: Sharma
authors.forename: Neha C
authors.initials: NC
authors.lastname: Virmani
authors.forename: Chetan
authors.initials: C
authors.lastname: Oberai
keywords: Kojic acid; MASI score; melasma
references.citation: Br J Dermatol. 1993 Oct;129(4):415-21
references.pmid: 8217756
references.citation: Arch Dermatol. 1994 Jun;130(6):727-33
references.pmid: 8002642
references.citation: Dermatol Surg. 1999 Apr;25(4):282-4
references.pmid: 10417583
references.citation: Indian J Dermatol. 2012 Jul;57(4):324-6
references.pmid: 22837578
references.citation: Indian J Dermatol. 2011 Jul;56(4):380-2
references.pmid: 21965843
references.citation: Arch Dermatol. 1975 Jan;111(1):40-8
references.pmid: 1119822
references.citation: J Am Acad Dermatol. 1981 Jun;4(6):698-710
references.pmid: 6787100
references.citation: Dermatol Surg. 1996 May;22(5):443-7
references.pmid: 8634807
references.citation: Contact Dermatitis. 1995 Jan;32(1):9-13
references.pmid: 7720390
references.citation: JAMA. 1967 Feb 27;199(9):601-5
references.pmid: 6071249
references.citation: Arch Dermatol. 1995 Dec;131(12):1453-7
references.pmid: 7492140
references.citation: J Am Acad Dermatol. 1986 Oct;15(4 Pt 2):894-9
references.pmid: 3534025
references.citation: Indian J Dermatol. 2009;54(4):303-9
references.pmid: 20101327